Kimberly-Clark Corporation (KMB) has seen several positive and negative developments recently. On the positive side, the company demonstrated a strong momentum for the long-term and raised its outlook for 2024. The company has reported first and second quarter results of 2024 already, showing solid organic growth and cost recoveries. A double upgrade has driven margin expansion that resulted in the stock hitting a 52-week high at $145.62. This momentum has been largely driven by the company's core strategy focus and its strategic transformation to unlock high-value growth opportunities. On the downside, weaker tissue demand has impacted its earnings and a few insiders, including the President of Latin America and Vice President, have sold company shares. Despite these challenges, Kimberly-Clark remains a favorite among institutional investors. The firm's appointment of Craig Slavtcheff as the Chief Research and Development Officer and Patricia Corsi as Chief Growth Officer underscores the company's commitment to expanding its executive leadership with skilled talent.
Kimberly-Clark Corp KMB News Analytics from Mon, 18 Dec 2023 08:00:00 GMT to Sun, 01 Sep 2024 13:28:05 GMT -
Rating 7
- Innovation 3
- Information 8
- Rumor -2
